MedDataX Logo

Sexual Dysfunction in Palliative Care Patients: An Assessment of Patient's Perspective

NCT ID: NCT05837117

Last Updated: 2024-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

104 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-12-15

Study Completion Date

2024-12-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To learn about the communications that Supportive Care patients receive about sexual well-being from their healthcare provider. Researchers also want to learn about your attitudes, beliefs, and feelings about sexual well-being.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary Objectives:

1. To determine the frequency of discussion about sexual dysfunction in palliative care patients.
2. To evaluate the impact of cancer diagnosis and treatment on patient's sexual life.

Secondary Objectives:

1. To evaluate patient self-reported severity of sexual dysfunction
2. To evaluate the proportion of patients suffering distress from body image concerns
3. To identify patient self-reported barriers that prevent discussion about sexual dysfunction
4. To evaluate patient self-reported impact of sexual dysfunction on their wellbeing

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sexual Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient's Perspective

Participants will complete a questionnaire about sexual wellbeing, sexual dysfunction, and communication with your provider on this topic. Participants may choose to complete the questionnaire electronically (via email link), in-person, or over the phone, whichever you prefer. Your demographic information (such as age, gender, ethnicity, marital status, and cancer diagnosis) will be collected from your medical record. Some of this information may also be asked of you during the questionnaire.

Patient's Perspective

Intervention Type BEHAVIORAL

Participants will complete a questionnaire about sexual wellbeing, sexual dysfunction, and communication with your provider on this topic.

Participants/Researchers will learn about your attitudes, beliefs, and feelings about sexual well-being

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patient's Perspective

Participants will complete a questionnaire about sexual wellbeing, sexual dysfunction, and communication with your provider on this topic.

Participants/Researchers will learn about your attitudes, beliefs, and feelings about sexual well-being

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients who are evaluated as follow-ups in the Supportive Care clinic, and able to voluntarily consent to participate in the study
* Patients must be able to understand, read, write, and speak English
* Diagnosis of cancer
* Patients who are 18 years of age or older

Exclusion Criteria

* New patients (consults)
* Patient who have declined to participate, or who are unable to consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

M.D. Anderson Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Patricia Bramati, MD

Role: PRINCIPAL_INVESTIGATOR

M.D. Anderson Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

M D Anderson Cancer Center

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

http://www.mdanderson.org

M D Anderson Cancer Center

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NCI-2022-10774

Identifier Type: OTHER

Identifier Source: secondary_id

2022-0495

Identifier Type: -

Identifier Source: org_study_id